Wisler Gerald 4
4 · Omthera Pharmaceuticals, Inc. · Filed Apr 11, 2013
Insider Transaction Report
Form 4
Wisler Gerald
DirectorPresident and CEO
Transactions
- Award
Warrant (right to buy)
2013-04-11+3,125→ 3,125 totalExercise: $0.01From: 2013-04-16Exp: 2023-02-15→ Common Stock (3,125 underlying) - Award
Secured Convertible Promissory Note
2013-04-11+12,664→ 12,664 totalExercise: $8.00From: 2013-04-16Exp: 2014-02-15→ Common Stock (12,664 underlying)
Footnotes (4)
- [F1]Upon the closing of the Issuer's initial public offering ("IPO"), the warrant will automatically convert into the number of shares of Common Stock shown in column 5 less the number of shares equal to the payment of the exercise price.
- [F2]Upon the closing of the Issuer's IPO, the note will convert into the number of shares of Common Stock shown in column 5.
- [F3]The Secured Convertible Promissory Note was issued to the reporting person in exchange for $100,000.
- [F4]This is the maturity date of the Secured Convertible Promissory Note.